Varex Imaging (NASDAQ:VREX) Issues Q1 2025 Earnings Guidance

Varex Imaging (NASDAQ:VREX) issued an update on its first quarter 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of -0.050-0.100 for the period, compared to the consensus earnings per share estimate of 0.040. The company issued revenue guidance of $195.0 million-$215.0 million, compared to the consensus revenue estimate of $189.4 million. Varex Imaging also updated its Q1 guidance to $(0.05)-$0.10 EPS.

Wall Street Analysts Forecast Growth

Separately, B. Riley started coverage on shares of Varex Imaging in a research note on Friday, August 23rd. They set a “buy” rating and a $21.00 target price for the company.

Varex Imaging Stock Performance

NASDAQ VREX traded up $0.44 during trading on Tuesday, reaching $14.56. The company’s stock had a trading volume of 1,277,780 shares, compared to its average volume of 489,539. Varex Imaging has a 12 month low of $10.19 and a 12 month high of $21.50. The firm has a 50 day moving average price of $12.35 and a 200 day moving average price of $13.46. The firm has a market capitalization of $595.50 million, a price-to-earnings ratio of 19.89 and a beta of 0.53. The company has a current ratio of 3.34, a quick ratio of 1.89 and a debt-to-equity ratio of 0.67.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.